REPATRIATION MEDICAL AUTHORITY
INSTRUMENT NO. 81 of 2010
VETERANS’ ENTITLEMENTS ACT 1986
MILITARY REHABILITATION AND COMPENSATION ACT 2004
EXPLANATORY NOTES FOR TABLING
- The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the VEA), Statement of Principles Instrument No. 81 of 2010 concerning rapidly progressive crescentic glomerulonephritis and death from rapidly progressive crescentic glomerulonephritis.
2. The Authority is of the view that there is sound medical-scientific evidence that indicates that rapidly progressive crescentic glomerulonephritis and death from rapidly progressive crescentic glomerulonephritis can be related to particular kinds of service. The Authority has therefore determined this Statement of Principles concerning rapidly progressive crescentic glomerulonephritis pursuant to subsection 196B(2) of the VEA.
3. Pursuant to the provisions of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA), claims for pension under the VEA or compensation under the MRCA are determined by the Repatriation Commission or the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.
4. The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:
operational service under the VEA;
peacekeeping service under the VEA;
hazardous service under the VEA;
warlike service under the MRCA;
non-warlike service under the MRCA,
before it can be said that a reasonable hypothesis has been raised connecting rapidly progressive crescentic glomerulonephritis or death from rapidly progressive crescentic glomerulonephritis, with the circumstances of that service.
5. The Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board, or Administrative Appeals Tribunal cannot accept any claim for pension; or a claim for liability or compensation relating to rapidly progressive crescentic glomerulonephritis or death from rapidly progressive crescentic glomerulonephritis that was lodged on or after 1 June 1994 in the case of the VEA, or 1 July 2004 in the case of the MRCA respectively, unless this Statement of Principles upholds that claim (subsection 120A(3) of the VEA or subsection 338(3) of the MRCA).
6. This new Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 13 January 2010 concerning rapidly progressive crescentic glomerulonephritis in accordance with section 196G of the VEA. The investigation involved an examination of the sound medical-scientific evidence available to the Authority.
7. Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to rapidly progressive crescentic glomerulonephritis in the Government Notices Gazette of 13 January 2010, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants. The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field. One submission was received for consideration by the Authority during the investigation.
8. The determining of this new Instrument finalises the investigation in relation to rapidly progressive crescentic glomerulonephritis as advertised in the Government Notices Gazette of 13 January 2010.
9. A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA. Any such request must be made in writing to the Repatriation Medical Authority at the following address:
The Registrar
Repatriation Medical Authority Secretariat
GPO Box 1014
BRISBANE QLD 4001
Overview
The Veterans’ Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA) form the legislative framework for providing medical and financial benefits to veterans and their dependants. The Repatriation Medical Authority Instrument No. 81 of 2010, issued under these Acts, addresses the medical condition of rapidly progressive crescentic glomerulonephritis and death from this condition, providing clear criteria for linking these conditions to specific types of military service. This instrument was enacted to fill a gap in the recognition of rapidly progressive crescentic glomerulonephritis as a condition related to military service, ensuring that claims for pension or compensation are substantiated by robust medical-scientific evidence. The Authority, as the determining body, has established the necessary conditions that must be met for these claims to be upheld, thereby facilitating the processing and assessment of such claims by the relevant commissions and tribunals.
Scope and Application
The Repatriation Medical Authority Instrument No. 81 of 2010, under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, establishes a Statement of Principles concerning rapidly progressive crescentic glomerulonephritis and death from this condition. This Statement of Principles applies to individuals who served in operational, peacekeeping, or hazardous service under the Veterans’ Entitlements Act, as well as those who served in warlike or non-warlike service under the Military Rehabilitation and Compensation Act. The Act applies to claims lodged on or after 1 June 1994 for pensions and 1 July 2004 for compensation, ensuring that the Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board, or Administrative Appeals Tribunal cannot accept any claims unless they are upheld by this Statement of Principles. The Authority's determination was based on sound medical-scientific evidence and follows an investigation advertised in the Government Notices Gazette on 13 January 2010.
Key Provisions
The Repatriation Medical Authority Instrument No. 81 of 2010, under the Veterans’ Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA), establishes a Statement of Principles concerning rapidly progressive crescentic glomerulonephritis and death from this condition. This statement outlines the specific factors that must be present and related to certain types of military service to support a claim that the condition is connected to the service (section 4). The types of service covered include operational, peacekeeping, and hazardous service under the VEA, and warlike and non-warlike service under the MRCA.
This legislative instrument imposes clear obligations on various entities and individuals involved in the claims process. The Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board, and Administrative Appeals Tribunal must adhere to this Statement of Principles when evaluating claims for pension or compensation related to rapidly progressive crescentic glomerulonephritis or death from this condition (section 5). Any claim lodged on or after 1 June 1994 under the VEA or 1 July 2004 under the MRCA must be supported by the criteria outlined in this Statement of Principles to be considered valid.
Failure to comply with the requirements set out in this Statement of Principles can lead to serious consequences. Claims that do not meet the criteria specified in the Statement will not be accepted by the relevant authorities (section 5). This non-compliance can result in the dismissal of a claim, thereby denying the claimant the pension or compensation they might otherwise be entitled to. The legislation does not explicitly outline specific penalties for non-compliance, but the implications are significant as they directly affect the eligibility and success of claims related to the specified condition.